ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Infectious Agents and Disease
Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1612124
Time Trend of Measles Burden on Children and Adolescents in BRICS-plus Countries from 1990 to 2021 and Prediction to 2032
Provisionally accepted- 1The First Affiliated Hospital of JinZhou Medical University, Jinzhou, Liaoning Province, China
- 2Collaborative Innovation Center for Prevention and Control of Zoonoses of Jinzhou Medical University, Jinzhou, Liaoning Province, China
- 3Modern Industrial School of Health Management, Jinzhou Medical University, Jinzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Measles remains a major disease burden on children and adolescents in BRICS-plus countries despite vaccine efficacy. This study aims to clarify the temporal trend of measles burden and forecast the trend in 2032.Data from the Global Burden of Disease(GBD) 2021 were utilized to analyze the prevalence, incidence, mortality, and disability-adjusted life years(DALYs) of measles in BRICS-plus countries. In addition, the association between the social development index(SDI) and measles-related indicators of children and adolescents in BRICS-plus countries was analyzed. Joinpoint regression was performed to identify temporal trends, while the age-period-cohort model was used to assess demographic effects. The Bayesian Age-Period-Cohort(BAPC) and Autoregressive Integrated Moving Average (ARIMA) models were utilized to project indicators to 2032. From 1990 to 2021, the global prevalence of measles dropped by 92% (with an average annual decline of 6.80%), and the average annual decline rates for incidence, mortality, and DALYs were 6.80%, 8.02%, and 8.02%, respectively. Saudi Arabia had a 100% reduction in prevalence(with an average annual decrease of 15.20%), Ethiopia had the highest DALYs(124,542.02),and Russia had the lowest DALYs (1.74). SDI was negatively linked to the measles prevalence(R = -0.703, p < 0.001), and an increase in SDI significantly reduced the burden of measles. The prevalence of measles was highest among children under 5 years old and slightly higher in males than in females.Joinpoint analysis indicated that the global burden of measles declined, but its mortality in China sharply increased from 2019 to 2021(APC = 191.88). The BAPC model predicted that by 2032, the global burden of measles will continue to decline, India will still have the highest prevalence(130.96), Russia may have no new cases, and Brazil and South Africa will have controllable local risks. ARIMA models showed similar trends. The declining burden of measles in BRICS-plus countries is correlated with SDI improvement, but low-income countries such as Ethiopia still face a high burden of measles. Children under five years and regions with low vaccination rates require prioritized interventions. The burden of measles will continue to decrease in the next decade, and increasing vaccination coverage in high-burden countries will help achieve the goal of measles elimination.
Keywords: Measles, BRICS-Plus, Joinpoint, age-period-cohort model, Bayesian age-period-cohort, ARIMA
Received: 15 Apr 2025; Accepted: 04 Jul 2025.
Copyright: © 2025 Yuan, Yan, Chong, Wang and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yong Jiang, Modern Industrial School of Health Management, Jinzhou Medical University, Jinzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.